These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 22385985

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis.
    Lonardo A, Ballestri S, Adinolfi LE, Violi E, Carulli L, Lombardini S, Scaglioni F, Ricchi M, Ruggiero G, Loria P.
    Can J Gastroenterol; 2009 Apr; 23(4):273-8. PubMed ID: 19373421
    [Abstract] [Full Text] [Related]

  • 28. Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: an observational, multicenter study in Turkey.
    Aksu HS, Kurtaran B, Onlen Y, Namiduru M, Inkaya AC, Kandemir O, Doran F, Evirgen O, Alpay Y, Tekin SK, Kurekci Y, Unlu B, Midikli D, Taşova Y, Ozdener F, Erdogan S.
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1393-9. PubMed ID: 23114743
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease.
    Tsai PS, Cheng YM, Wang CC, Kao JH.
    Eur J Gastroenterol Hepatol; 2023 Nov 01; 35(11):1278-1283. PubMed ID: 37773778
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
    Puig J, Blasco G, Daunis-I-Estadella J, Loshuertos E, Codina J, Cuba V, Ortiz R, Xifra G, Ricart W, Pedraza S, Federici M, Fernández-Real JM.
    Clin Endocrinol (Oxf); 2015 Aug 01; 83(2):180-6. PubMed ID: 25510350
    [Abstract] [Full Text] [Related]

  • 34. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
    Ozturk K, Uygun A, Guler AK, Demirci H, Ozdemir C, Cakir M, Sakin YS, Turker T, Sari S, Demirbas S, Karslıoğlu Y, Saglam M.
    Atherosclerosis; 2015 Jun 01; 240(2):380-6. PubMed ID: 25875390
    [Abstract] [Full Text] [Related]

  • 35. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y, Kanda T, Sasaki R, Nakamura M, Nakamoto S, Yokosuka O.
    World J Gastroenterol; 2015 Dec 14; 21(46):12989-95. PubMed ID: 26675364
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes.
    Guo K, Zhang L, Lu J, Yu H, Wu M, Bao Y, Chen H, Jia W.
    J Diabetes Complications; 2017 Jan 14; 31(1):80-85. PubMed ID: 27742552
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.